Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
13
×
national blog main
san francisco blog main
13
×
life sciences
new york blog main
san francisco top stories
boston blog main
national top stories
new york top stories
boston top stories
detroit blog main
detroit top stories
national
raleigh-durham blog main
wisconsin blog main
boulder/denver blog main
boulder/denver top stories
raleigh-durham top stories
san diego blog main
san diego top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin top stories
clinical trials
fda
indiana blog main
indiana top stories
cancer
eli lilly
pfizer
startups
cancer immunotherapy
investing
ipo
merck
renaissance capital
abbvie
alzheimer's disease
What
week
13
×
bio
roundup
ipo
life
science
companies
moves
biotech
company
drug
medicine
public
street
wall
way
based
biogen
biotechs
ceo
close
debut
firms
group
haul
ipos
medical
million
momentum
new
raised
research
sciences
therapeutics
welcomed
acquisitions
adu
alzheimer’s
america
ann
Language
unset
Current search:
week
×
biotech
×
" san francisco blog main "
×
@xconomy.com
3 years ago
Bio Roundup: SeaGen Scores, Dyne’s Debut, Microbiome Moves & More
@xconomy.com
3 years ago
Two Days, Six IPOs, and $1B Raised for Biotech Research & More
@xconomy.com
4 years ago
Bio Roundup: Mammoth Moves, Black Diamond’s Pop, Ohana’s Debut & More
@xconomy.com
4 years ago
Liquid Biopsy Firm Lucence Plans Bay Area Buildout With $20M in Tow
@xconomy.com
4 years ago
SpringWorks and Satsuma Boost This Week’s Biotech IPO Haul to $595M
@xconomy.com
5 years ago
Bio Roundup: Head and Spine Previews, Biogen Moves, IPO Dreams & More
@xconomy.com
5 years ago
Bio Roundup: Sage Postpartum Help, Biogen Bids Adu, Heart Beats & More
@xconomy.com
5 years ago
Bio Roundup: Bosley’s Editas Exit, Bridge Bucks, CRISPR Crime & More
@xconomy.com
5 years ago
Bio Roundup: Moderna’s IPO, Arena’s Comeback, E-Cig Survey & More
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Puzzle, ESMO Assessed, Drug Prices & More
@xconomy.com
5 years ago
Six Life Science Firms Close Q3 with an IPO, More Are on the Way
@xconomy.com
5 years ago
IPO Wave Rolls On as Five Life Science Firms Haul in $651M
@xconomy.com
5 years ago
Pfizer, Merck Lead Strata Oncology’s $26M Series B Round